The WACC of Lipigon Pharmaceuticals AB (LPGO.ST) is 4.5%.
| Range | Selected | |
| Cost of equity | 2.50% - 7.40% | 4.95% |
| Tax rate | 20.60% - 20.90% | 20.75% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 3.2% - 5.7% | 4.5% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | -0.29 | 0.39 |
| Additional risk adjustments | 1.5% | 2.0% |
| Cost of equity | 2.50% | 7.40% |
| Tax rate | 20.60% | 20.90% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 3.2% | 5.7% |
| Selected WACC | 4.5% | |